-
Something wrong with this record ?
Acute Kidney Injury in Deceased Organ Donors: Risk Factors And Impacts on Transplantation Outcomes
K. Jakubov, V. Petr, I. Zahradka, E. Girmanova, P. Hruba, R. Keleman, O. Viklicky
Status not-indexed Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2015
PubMed Central
from 2015
Europe PubMed Central
from 2015
ROAD: Directory of Open Access Scholarly Resources
from 2015
- Publication type
- Journal Article MeSH
BACKGROUND: Acute kidney injury in deceased donors (D-AKI) is one of the common causes of donor kidney discard. The risk factors for D-AKI and its impact on kidney transplantation outcomes are not yet fully understood. METHODS: This single-center, retrospective cohort study included 388 donors referred between June 2021 and December 2022. D-AKI was defined and staged according to kidney disease: Improving global outcomes criteria, and donor clinical variables were analyzed to identify risk factors for D-AKI. Delayed graft function and estimated glomerular filtration rate (eGFR) at 6 mo were evaluated in 369 kidney grafts transplanted from donors with and without D-AKI. RESULTS: AKI was present in 171 deceased donors (44.1%), with 117 (30.2%) classified as AKI stage 1 and 54 (14%) as AKI stages 2 or 3. Donor history of hypertension (odds ratio [OR] 1.93; 95% confidence interval [CI], 1.21-3.10; P = 0.005), history of diabetes (OR 2.2; 95% CI, 1.21-3.98; P = 0.008), and anoxia as the cause of death (OR 2.61; 95% CI, 1.5-4.61; P < 0.001) were independently associated with an increased risk of D-AKI. Multivariable mixed models identified donor age (β -0.49; 95% CI, -0.71 to -0.28; P < 0.001) as the only independent risk factor for lower eGFR at 6 mo. D-AKI was not associated with delayed graft function or lower eGFR at 6 mo. CONCLUSIONS: Hypertension, diabetes, and anoxia as the cause of death were identified as risk factors for AKI in deceased donors. D-AKI should not be used as the sole criterion to assess the risk of poor graft outcomes. A broader range of donor variables should be considered when evaluating graft viability.
Department of Nephrology Institute for Clinical and Experimental Medicine Prague Czech Republic
Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002033
- 003
- CZ-PrNML
- 005
- 20250123101946.0
- 007
- ta
- 008
- 250117s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/TXD.0000000000001730 $2 doi
- 035 __
- $a (PubMed)39553743
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jakubov, Katarina $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 245 10
- $a Acute Kidney Injury in Deceased Organ Donors: Risk Factors And Impacts on Transplantation Outcomes / $c K. Jakubov, V. Petr, I. Zahradka, E. Girmanova, P. Hruba, R. Keleman, O. Viklicky
- 520 9_
- $a BACKGROUND: Acute kidney injury in deceased donors (D-AKI) is one of the common causes of donor kidney discard. The risk factors for D-AKI and its impact on kidney transplantation outcomes are not yet fully understood. METHODS: This single-center, retrospective cohort study included 388 donors referred between June 2021 and December 2022. D-AKI was defined and staged according to kidney disease: Improving global outcomes criteria, and donor clinical variables were analyzed to identify risk factors for D-AKI. Delayed graft function and estimated glomerular filtration rate (eGFR) at 6 mo were evaluated in 369 kidney grafts transplanted from donors with and without D-AKI. RESULTS: AKI was present in 171 deceased donors (44.1%), with 117 (30.2%) classified as AKI stage 1 and 54 (14%) as AKI stages 2 or 3. Donor history of hypertension (odds ratio [OR] 1.93; 95% confidence interval [CI], 1.21-3.10; P = 0.005), history of diabetes (OR 2.2; 95% CI, 1.21-3.98; P = 0.008), and anoxia as the cause of death (OR 2.61; 95% CI, 1.5-4.61; P < 0.001) were independently associated with an increased risk of D-AKI. Multivariable mixed models identified donor age (β -0.49; 95% CI, -0.71 to -0.28; P < 0.001) as the only independent risk factor for lower eGFR at 6 mo. D-AKI was not associated with delayed graft function or lower eGFR at 6 mo. CONCLUSIONS: Hypertension, diabetes, and anoxia as the cause of death were identified as risk factors for AKI in deceased donors. D-AKI should not be used as the sole criterion to assess the risk of poor graft outcomes. A broader range of donor variables should be considered when evaluating graft viability.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Petr, Vojtech $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Zahradka, Ivan $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Girmanova, Eva $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Hruba, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Keleman, Roman $u Department for organ Procurement , Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Viklicky, Ondrej $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department for organ Procurement , Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000310492195 $7 nlk20050170291
- 773 0_
- $w MED00195744 $t Transplantation direct $x 2373-8731 $g Roč. 10, č. 12 (2024), s. e1730
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39553743 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250123101940 $b ABA008
- 999 __
- $a ok $b bmc $g 2254451 $s 1238036
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 10 $c 12 $d e1730 $e 20241114 $i 2373-8731 $m Transplantation direct $n Transplant Direct $x MED00195744
- LZP __
- $a Pubmed-20250117